From: The measurement of response shift in patients with advanced prostate cancer and their partners
Months 0 – 3 |  |  | Months 3 – 6 |  |  |
---|---|---|---|---|---|
Pre-test – Then-test ('Response Shift') (p*) | Patients (n = 53) | 0.4 (0.1) | Pre-test – Then-test ('Response Shift') (p*) | Patients (n = 53) | 0.2 (0.1) |
 | 95% C.I. | -0.1 – 0.8 |  | 95% C.I. | -0.5 – 0.6 |
 | Partners (n = 41) | 0.3 (0.3) |  | Partners (n = 38) | 1.6 (<0.001) |
 | 95% C.I. | -0.3 – 0.8 |  | 95% C.I. | 1.0 – 2.2 |
Pre-test – Post-test ('Traditional Change') (p*) | Patients (n = 53) | 0.04 (0.8) | Pre-test – Post-test ('Traditional Change') (p*) | Patients (n = 53) | -0.1 (0.6) |
 | 95% C.I. | -0.3 – 0.3 |  | 95% C.I. | -0.4 – 0.2 |
 | Partners (n = 41) | 0.5 (0.02) |  | Partners (n = 38) | -0.7 (0.004) |
 | 95% C.I. | 0.06 – 0.9 |  | 95% C.I. | -1.2 – 0.2 |
Then-test – Post-test ('Actual Change') (p*) | Patients (n = 53) | 0.4 (0.1) | Then-test – Post-test ('Actual Change') (p*) | Patients (n = 53) | 0.1 (0.3) |
 | 95% C.I. | -0.04 – 0.8 |  | 95% C.I. | -0.3 – 0.1 |
 | Partners (n = 41) | 0.8 (0.001) |  | Partners (n = 38) | 0.9 (0.001) |
 | 95% C.I. | 0.3 – 1.2 |  | 95% C.I. | 0.4 – 1.4 |